Literature DB >> 18632216

Long-term results and prognostic factors of fractionated strontium-90 eye applicator for pterygium.

Gustavo Arruda Viani1, Eduardo Jose Stefano, Ligia Issa De Fendi, Ellen Carrara Fonseca.   

Abstract

PURPOSE: To evaluate the long-term safety, effectiveness, and prognostic factors of fractionated postoperative beta-irradiation. METHODS AND MATERIALS: Between 1993 and 2005, 623 patients with 737 pterygium lesions were treated with a strontium-90 eye applicator after surgical excision. The median follow-up period was 60 months (range, 6.7-139.5). Of the 737 lesions, 644 were primary and 93 were recurrences after surgical removal alone. Fractionated radiotherapy (RT) to a total dose of 35 Gy in five to seven fractions was used.
RESULTS: A total of 73 local pterygium recurrences (9.9%) were noted. Of the recurrent cases, 80% were noted within 3 years after treatment. The 5- and 10-year probability of local control was 90% and 88%, respectively. The multivariate analysis for all cases demonstrated that gender, age, total radiation dose, recurrent pterygia, and interval between surgery and RT affected the overall local control rate. Late toxicities that might have been associated with strontium-90 RT included scleromalacia (scleral thinning) in nine eyes, adhesion of the eyelids in eight, cataracts in six, and scleral ulcer in five eyes.
CONCLUSION: Fractionated strontium-90 RT to a total dose of approximately 35 Gy in five to seven fractions results in a similar local control rate as higher doses in other series, with an acceptable complication rate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632216     DOI: 10.1016/j.ijrobp.2008.02.075

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

Review 1.  [Operative techniques for surgical treatment of primary and recurrent pterygia].

Authors:  W Sekundo; K Droutsas; C Cursiefen
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

2.  [Pterygium surgery. Complication following adjuvant radiotherapy].

Authors:  C Lange; D Böhringer; T Reinhard
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

3.  Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up.

Authors:  Iraklis Vastardis; Bojan Pajic; Richard H Greiner; Brigitte Pajic-Eggspuehler; Daniel M Aebersold
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

Review 4.  Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis.

Authors:  Wen Zeng; Zengming Liu; Hanjun Dai; Ming Yan; Hong Luo; Min Ke; Xiaojun Cai
Journal:  BMC Ophthalmol       Date:  2017-11-25       Impact factor: 2.209

Review 5.  How to minimize pterygium recurrence rates: clinical perspectives.

Authors:  Raffaele Nuzzi; Federico Tridico
Journal:  Clin Ophthalmol       Date:  2018-11-19

6.  Changes of Corneal Biomechanical Properties upon Exclusive Ytt-/Sr-90 Irradiation of Pterygium.

Authors:  Fritz Rigendinger; Daniel M Aebersold; Zeljka Cvejic; Bojan Pajic
Journal:  Sensors (Basel)       Date:  2021-02-02       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.